Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methotrexate + vinblastine for unresectable aggressive desmoid tumor
jRCTs041180009Recruiting
- Start
- Feb 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of methotrexate and vinblastine in aggressive fibromatosis (AF). Primary endpoint: Safety. Started Feb 2018; status: recruiting.
02
Drugs
methotrexatevinblastine
03
Conditions
aggressive fibromatosis (AF)
Beyond the preview
Go deeper on jRCTs041180009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180009.